0001683168-22-002485.txt : 20220411
0001683168-22-002485.hdr.sgml : 20220411
20220411090020
ACCESSION NUMBER: 0001683168-22-002485
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220331
FILED AS OF DATE: 20220411
DATE AS OF CHANGE: 20220411
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Loehr Matthias
CENTRAL INDEX KEY: 0001922103
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40699
FILM NUMBER: 22818578
MAIL ADDRESS:
STREET 1: 3960 HOWARD HUGHES PARKWAY
STREET 2: SUITE 500
CITY: LAS VEGAS
STATE: NV
ZIP: 89169
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PharmaCyte Biotech, Inc.
CENTRAL INDEX KEY: 0001157075
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 621772151
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0430
BUSINESS ADDRESS:
STREET 1: 23046 AVENIDA DE LA CARLOTA, SUITE 600
CITY: LAGUNA HILLS
STATE: CA
ZIP: 92653
BUSINESS PHONE: (917) 595.2850
MAIL ADDRESS:
STREET 1: 23046 AVENIDA DE LA CARLOTA, SUITE 600
CITY: LAGUNA HILLS
STATE: CA
ZIP: 92653
FORMER COMPANY:
FORMER CONFORMED NAME: NUVILEX, INC.
DATE OF NAME CHANGE: 20090324
FORMER COMPANY:
FORMER CONFORMED NAME: EFOODSAFETY COM INC
DATE OF NAME CHANGE: 20010808
3
1
ownership.xml
X0206
3
2022-03-31
0
0001157075
PharmaCyte Biotech, Inc.
PMCB
0001922103
Loehr Matthias
3960 HOWARD HUGHES PARKWAY, SUITE 500
LAS VEGAS
NV
89169
1
0
0
0
Common Stock
3004
I
By BB Biomed Consulting GMBH
The number of shares has been adjusted to reflect a one-for-1,500 reverse stock split of the Issuer's common stock effected on July 12, 2021.
/s/ Matthias Loehr
2022-04-11